Search research articles
Contact Us
Filters
Showing results (151-160 of 204) with videos related to
Page
of 21
Sort By:
Blood
|
April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
Xiaoli Wang, David Haylock, Cing Siang Hu, et al.
Blood Cells, Molecules & Diseases
|
March 14, 2007
The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia
Vittorio Rosti, Margherita Massa, Alessandro M Vannucchi, et al.
Experimental Hematology
|
September 5, 2016
Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis
Ilaria Ceglia, Amylou C Dueck, Francesca Masiello, et al.
Transfusion
|
December 6, 2019
Pre-clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice
Ami Patel, Cara Marie Clementelli, Danuta Jarocha, et al.
Leukemia
|
February 20, 2026
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images
Andrew Srisuwananukorn, Giuseppe Gaetano Loscocco, James M Dolezal, et al.
Leukemia Research
|
June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database
Douglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.
Leukemia Research
|
June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.
Blood
|
October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
Mingjiang Xu, Edward Bruno, Joseph Chao, et al.
Leukemia Research
|
September 4, 2012
Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium
John Mascarenhas, Mark L Heaney, Vesna Najfeld, et al.
Leukemia & Lymphoma
|
June 2, 2024
Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms
Blake Langlais, Amylou C Dueck, Heidi E Kosiorek, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 204) with videos related to
Sort By:
Page
of 21
Blood
|
April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
Xiaoli Wang, David Haylock, Cing Siang Hu, et al.
Blood Cells, Molecules & Diseases
|
March 14, 2007
The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia
Vittorio Rosti, Margherita Massa, Alessandro M Vannucchi, et al.
Experimental Hematology
|
September 5, 2016
Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis
Ilaria Ceglia, Amylou C Dueck, Francesca Masiello, et al.
Transfusion
|
December 6, 2019
Pre-clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice
Ami Patel, Cara Marie Clementelli, Danuta Jarocha, et al.
Leukemia
|
February 20, 2026
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images
Andrew Srisuwananukorn, Giuseppe Gaetano Loscocco, James M Dolezal, et al.
Leukemia Research
|
June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database
Douglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.
Leukemia Research
|
June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.
Blood
|
October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
Mingjiang Xu, Edward Bruno, Joseph Chao, et al.
Leukemia Research
|
September 4, 2012
Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium
John Mascarenhas, Mark L Heaney, Vesna Najfeld, et al.
Leukemia & Lymphoma
|
June 2, 2024
Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms
Blake Langlais, Amylou C Dueck, Heidi E Kosiorek, et al.
Page
of 21